Medical
Novotech at ESMO Congress 2022 – New Data Shows 100% Oncology Trials Growth in APAC
Meet the team at Booth #409 Novotech, the leading Asia Pacific biotech specialist CRO, will attend ESMO Congress 2022 with new data showing Asia...
Medical
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a report now available titled "Evolution of Clinical Trials in...
Medical
Novotech’s Flexible Work Policy is Finalist in Best Workplace Flexibility Program “Excellence Award 2022”
Novotech, the leading Asia Pacific biotech specialist CRO with expanded services in the US, has been recognised for its innovative approach to workplace flexibility. Novotech...
Medical
Novotech and Endpoints Present “Evolution of Cell & Gene Therapy in China: The Case for Universal CAR-T”
Novotech, the leading Asia Pacific biotech specialist CRO with expanded services in the US, is pleased to present an Endpoints webinar on CAR-T therapy...
Medical
Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, congratulates its client SK bioscience on the...
Medical
Novotech Receives “Best Biologics CRO Award 2022” at Korea Bioprocessing Excellence Awards 2022
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was today awarded the Best Biologics CRO...
Medical
Novotech Receives CRO Leadership Award for Exceeding Customer Expectations
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded a prestigious Clinical Leader and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
